A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
Clinical trial NCT01772472 · COMPLETED
Trial details
- NCT number
- NCT01772472
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-03
- Primary completion
- 2018-07-25
- Enrollment
- 1486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.